Recent Analyst Forecasts and Stock Ratings
Neurocrine Biosciences, Inc. FAQ's
Neurocrine Biosciences, Inc. has been rated by research analysts at Guggenheim, Cantor Fitzgerald, UBS, Morgan Stanley, RBC Capital, Bernstein in the past 90 days.
Neurocrine Biosciences, Inc. has been rated by research analysts at Guggenheim, Cantor Fitzgerald, UBS, Morgan Stanley, RBC Capital, Bernstein in the past 90 days.